Ghosh Anirvan 4
4 · Unity Biotechnology, Inc. · Filed Mar 31, 2025
Insider Transaction Report
Form 4
Ghosh Anirvan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-28+286,000→ 286,000 totalExercise: $1.67Exp: 2035-03-27→ Common Stock (286,000 underlying) - Award
Common Stock, $0.0001 par value
2025-03-28+175,000→ 250,251 total
Footnotes (3)
- [F1]On January 30, 2024, the Board of Directors granted the Reporting Person 175,000 Restricted Stock Units ("RSUs") that vest in full upon the satisfaction of certain performance criteria, which were met on March 28, 2025.
- [F2]Includes RSUs that vest over time measured from the grant date.
- [F3]On January 30, 2024, the Board of Directors granted the Reporting Person an option to purchase 286,000 shares of common stock. The underlying shares vest and become exercisable pursuant to the following schedule: one half of the shares subject to the option vest upon the satisfaction of certain performance criteria, which were met on March 28, 2025, and the remaining shares subject to the option vest in 12 successive, equal monthly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.